Soleno Therapeutics, Inc.
SLNO
$33.39
-$0.37-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 305.47M | 498.93M | 286.84M | 289.95M | 291.44M |
| Total Receivables | 28.21M | 25.51M | 24.62M | -- | -- |
| Inventory | 15.02M | 6.67M | 2.36M | -- | -- |
| Prepaid Expenses | 7.11M | 3.74M | 2.97M | 5.87M | 2.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 13.10M | -- |
| Total Current Assets | 355.81M | 534.85M | 316.79M | 308.92M | 293.89M |
|
|
|||||
| Total Current Assets | 355.81M | 534.85M | 316.79M | 308.92M | 293.89M |
| Net Property, Plant & Equipment | 2.38M | 2.46M | 2.60M | 2.78M | 2.98M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.86M | 5.35M | 5.83M | 6.32M | 6.81M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 163.00K | 83.00K | 83.00K | 83.00K | 83.00K |
| Total Assets | 563.83M | 599.90M | 332.31M | 318.09M | 330.97M |
|
|
|||||
| Total Accounts Payable | 12.44M | 8.15M | 6.22M | 5.48M | 8.88M |
| Total Accrued Expenses | 27.82M | 24.30M | 8.54M | 6.52M | 9.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 726.00K | 697.00K | 676.00K | 597.00K | 526.00K |
| Total Finance Division Other Current Liabilities | 20.38M | 107.00K | 5.51M | 3.13M | -- |
| Total Other Current Liabilities | 20.38M | 107.00K | 5.51M | 3.13M | -- |
| Total Current Liabilities | 61.36M | 33.25M | 20.94M | 15.73M | 18.75M |
|
|
|||||
| Total Current Liabilities | 61.36M | 33.25M | 20.94M | 15.73M | 18.75M |
| Long-Term Debt | 49.86M | 49.85M | 49.85M | 49.84M | 49.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.96M | 2.11M | 2.25M | 2.36M | 2.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 525.00K | 19.87M | 19.13M | 17.90M | 14.81M |
| Total Liabilities | 113.72M | 105.09M | 92.17M | 85.83M | 85.86M |
|
|
|||||
| Common Stock & APIC | 881.07M | 969.17M | 740.80M | 728.07M | 697.01M |
| Retained Earnings | -431.37M | -474.73M | -500.74M | -496.03M | -452.26M |
| Treasury Stock & Other | 415.00K | 360.00K | 85.00K | 226.00K | 361.00K |
| Total Common Equity | 450.12M | 494.81M | 240.14M | 232.26M | 245.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 450.12M | 494.81M | 240.14M | 232.26M | 245.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 450.12M | 494.81M | 240.14M | 232.26M | 245.11M |
|
|
|||||